S U N D A Y , March 19, 2023
16.30-17.30
SATELLITE SYMPOSIUM (SAT I)
Industry sponsored Satellite
(AbbVie Deutschland GmbH)
Lecture Hall III (Overflow Rooms: LHs IV+V)
Transforming the AML Treatment Paradigm: An Expert Conversation
16.30-16.35
Welcome and Introduction
H. Döhner, Ulm, DE
16.35-16.45
Changing Foundations in AML Treatment
G. Roboz, New York, NY, USA
16:45-16:55
Building on New Treatment Approaches
Ch. Craddock, Birmingham, UK
16:55-17.25
Panel Discussion and Q&A
All Faculty
17:25-17.30
Closing Remarks
H. Döhner, Ulm, DE
M O N D A Y , March 20, 2023
12:45-13:45
SATELLITE SYMPOSIUM (SAT II)
Industry sponsored Satellite
(Pfizer GmbH)
Lecture Hall III (Overflow Rooms: LHs IV/V)
Targeted treatment in ALL and AML
12:45-12:50
Welcome and Introduction
12:50-13:10
M. Subklewe, Munich, DE
13:10-13:30
R. Wäsch, Freiburg, DE
13:30-13:45 Q & A
18:00-19:00
SATELLITE SYMPOSIUM (SAT III)
Industry sponsored Satellite
(Bristol Myers Squibb)
Lecture Hall III (Overflow Rooms: LHs IV/V)
Maintenance in AML: How far Have we Come and Where are we Headed?
18:00-18:10
Welcome and Introduction
Gail JH. Roboz (Chair)
Weill Cornell Medical College
New York, NY, USA
18:10-18:30
How do I Maintain Remission in Patients with AML?
Klaus H. Metzeler
University Hospital Leipzig
Germany
18:30-18:50
Thomas Cluzeau
University Hospital of Nice
France
18.50-19:00
Q & A and Closing Remarks
Gail J. Roboz, Klaus H. Metzeler, and Thomas Cluzeau
T U E S D A Y, March 21, 2023
16:00-17:00 SATELLITE SYMPOSIUM (SAT IV)
Industry sponsored Satellite
(Jazz Pharmaceuticals)
Lecture Hall III (Overflow Rooms LHs IV+V)
Evidence-Based Practice for High-Risk AML:
Classifications, Clinical Studies, and the Real World
16:00-16.02
Welcome and Introduction
L. Bullinger, Berlin, DE
16:02-16:17
High-Risk AML in 2023 – Have our New Classifications Improved our Management of Patients?
L. Bullinger, Berlin, DE
16:17-17:32
From Clinical Trials to the Clinic: Why Real-World Evidence Matters.
A. Venditti, Rome, I
17:32-17:48
Case Study Debate: Integrating Knowledge from Clinical Studies
and Real-World Evidence
Th. Schroeder, Essen, DE
17:48-17:58 Audience: Q&A
17:58-18:00 Close
L. Bullinger, Berlin, DE